A multicenter, prospective randomized phase III study to compare efficacy and safety of high dose immunoablation and autologous hematopoietic stem cell transplantation with intravenous pulse therapy cyclophosphamide for the treatment of patients with severe systemic sclerosis.
Principal Investigators:

Study Administration:

 

Email:

 

Study Chair:

 

 

 

 

 

 

 

 

 

 

 

 EBMT/EULAR SCLERODERMA STUDY GROUP                                                           

I. de Jonge, Dept. of Epidemiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. Tel : +31 71 5262501, Fax : +31 71 5266994

astistrial@lumc.nl  

 

J.M. van Laar, Musculoskeletal Research Group, Institute of Cellular Medicine, School of Clinical Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom. Tel. 44 - 191 - 222 7139, Fax: +44 - 191 - 222 5455

E-mail: j.m.van-laar@ncl.ac.uk

 

D. Farge, Dept. of Internal Medicine, Hôpital Saint-Louis, 1 Avenue Claude Vellefaux, F-75475 Paris Cédex 10, France. Tel: 33 – 1 – 42 499768, Fax: 33 – 1-  2 499478, 

E-mail: dominique.farge-bancel@sls.ap-hop-paris.fr          logo_StLouis.jpg (4925 bytes)

 

A.Tyndall, Dept. of Rheumatology, Felix-Platter Spital, Burgfelder Strasse 101, 4055 Basel,  Switzerland. Tel: 41 – 61 – 3264003, Fax: 41 – 61 –3264010,

E-mail: alan.tyndall@fps-basel.ch fps_logo.jpg  

 
Writing Committee:

 

         

Statistical Analysis:

 

Data Management:

 J.M. van Laar (Newcastle upon Tyne), D. Farge (Paris), A. Tyndall (Basel), J.K. Sont (Leiden), A. Gratwohl (Basel), H.H. Peter (Freiburg), F.H.J. van den Hoogen (Nijmegen), W.E. Fibbe (Leiden)                                                                

J.K. Sont (Leiden)    lumc.jpg (2204 bytes)

 

I. De Jonge, J.K. Sont (Leiden)

Home | News | Protocol | Side Studies | Patient Info | Meetings | Participating Centers | Members | Links
Up

 

This page is maintained by Dr J.K. Sont, E-mail

Last change: 11 January 2008